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ABSTRACT
Valentina Lootens. M.S., Department of Economics, Wright State University, 2006.
Assessment of the Technology of Genetic Modification In Light o f Its Socio-economic
Implications
Since Watson and Crick discovered the “double helix” in 1953, the arguments
about the benefits and danger of genetic modification remain largely unanswered,
particularly in the relation to food supply. Today, genetic modification or genetic
engineering are global issues. Governments, scientific organizations, corporations,
research institutions, and scholars hotly dispute the advantages and disadvantages of GM
technology. However, unfortunately, the population at large is left in darkness about this
new technology and its consequences for human health, environment and society.
Moreover, genetic engineering creates a special problem: unlike many new technologies
it is irreversible. Once introduced into the food chain, GM gene is hard and costly to trace
and impossible to revert. The long-term outlook can be devastating: unleashed and
unmanageable GM traits will forever change our food, nature and, thus, ourselves.
Analytical models and the field data raise alarming questions about the long-term
effects of GM on human health, coexistence of different farming methods, extinction o f
certain species, disruption of the food chain, pollen cross-contamination, new allergies,
mutations, new diseases, disadvantaged communities, inability to practice religions and
beliefs, etc.
The results of this study are alarming: long-term effects o f the rapidly diffusing
technology of genetic modification are largely unknown, short-term effects are disagreed
upon, and there are no signs o f large societal benefit to date o f this technology. This
brings the question: Are biotech’s perceived benefits worth the exposure to a potential
large-scale catastrophe?
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1. Introduction
Globalization, economic growth, and rapid technological changes are signs o f the
twenty first century. The world is “growing” in several directions: technological,
economic, political, social, and cultural. In light of the constancy o f change, new ideas,
technologies, and products have very high value. Businesses o f all kinds strive for
efficient production in order to obtain the competitive advantage. The accumulation o f
capital, broadly defined to include physical, human, and knowledge capital, has become
the main goal of development. On the other hand, in the social sphere there are issues
such as poverty, malnutrition, and a rapidly growing population on the planet. The
comparatively new technology of Genetically Modified Foods offers a solution to
hunger and related social issues associated with economic development and integration.
Purpose of Study
This study examines the development and diffusion of GE and GM technologies
and its potential health, environmental, social, cultural, and economic implications. The
primary thesis of this study is that nations (particularly the U.S.) are pursuing a
potentially dangerous and reckless approach by embracing and promoting GE and GM
technologies without appropriate concerns for their potential side effects. The
technologies are diffusing very rapidly yet legitimate concerns about their long-term
effects on health, environment and culture remain unanswered. The purpose o f this
paper is to present both the positive and negative effects o f GE and GM products and to
support a policy framework dealing with these issues.

1

Outline o f Paper
Section 2 describes the uniqueness o f GM technology by defining genetic
modification and outlines the history o f this technology. Section 3 discusses diffusion of
the GE technology, the market structure, and the leading GM companies. Section 4
presents an extensive argument on the costs and benefits as well as the risks and
controversies o f Genetic Engineering. Section 5 is concerned with the policies and
regulations o f GM products in different countries. Section 6 discusses the socio-economic
implications of the genetic engineering in agriculture. Section 7 presents several
methodological approaches (including the Cost Benefit analysis) that are able to account
for these socio-economic implications. Finally, this paper offers recommendations
concerning the actions that can be taken by individuals, groups, and, especially,
governments when considering genetic modification.
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2. Genetic Modification and its Historical Outline
2. A Terms and Definitions.
The terms “Genetic engineering” (GE) and “Genetic Modification” (GM) are used
interchangeably. Genetic Modification is the process o f “manipulating genes, usually
outside the organism’s reproductive process.” The isolation, manipulation, and
introduction of DNA onto cells or model organisms are necessary parts o f GM
technology in order to express protein. The goal of such an introduction is to “impose”
certain characteristics or attributes (physiologically or physically) to create a new protein
or enzyme; for example, one that would produce crop tolerance to herbicides. Products
that have been exposed to genetic modification are said to be “genetically modified,”
“genetically engineered,” or “transgenic.” One application o f genetically modified
products is in the food industry. Food products derived from a genetically modified
organism (an organism with altered genetic material) - plant, crop, animal or microbe
such as yeast - are genetically modified foods. This alteration is achieved by using
recombinant DNA technology - the “ability to combine DNA molecules from different
sources into one molecule in a test tube” (Wikipedia). It is worth mentioning that this
technique is different from conventional cross breeding or “mutagenesis.” These methods
were used long before the discovery of DNA.
2.

B Historical Outline
In the scientific world, very few inventions are “radical to the field.” In fact, most

o f them build on the knowledge obtained in the past, which makes the rapid progress o f
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science possible. Thus, knowledge obtained by one scientist can be used as a platform for
the research of another scientist. The case of GM technology is no different. The process
of scientific discovery in the related fields started several centuries ago. Darvin’s theory
of evolution was published in 1859. In 1865, Gregor Mendel presented Experiments in
Plant Hybridization to the scientific community. Mendel found the inheritance patterns o f
certain traits in the pea plant and showed that it was possible to describe them
mathematically. The importance of M endel’s work was not understood until the twentieth
century, when his research served as a compass in the studies o f similar problems.
Mendel himself did not understand the nature of inheritance. It was in the year 1903 that
chromosomes were discovered to be hereditary units. Two years later, the British
biologist William Bateson introduced the term “genetics.” In 1910, it was found that
genes reside on chromosomes. In 1918, the publication o f Ronald Fisher on Mendelian
Inheritance started a new era in biology and science in general. This modem evolutionary
synthesis brought a connection between genes (the units of evolution) and selection (the
mechanism of evolution).
In 1927, physical changes in genes are said to be “mutations.” (1). In the 30s and
40s, the scientific community obtained a great deal of knowledge about genes: their
structure, functions, and applications. In 1953, James Watson and Francis Crick
described the DNA stmcture as a “double helix.” Another very important discovery for
genetic modification was made in 1970: the finding o f restriction enzymes (enzymes that
cut double-strand DNA), which enabled scientists to “cut and paste DNA.” The origins of
genetic engineering itself started with the Nobel prize-winning discovery o f DNA and the
production o f recombinant E.coli bacteria. This scientific advancement still plays an
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important role in the genetic modification. In fact, the first useful application of
recombinant DNA technology was the manipulation of E.coli to produce human insulin.
All o f these discoveries led to an era of genetic engineering and research in this sphere.
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3. Development of the GM Technology and GM Food Market
3. A The Application of the GM Technology
The era o f Genetic Modification brought about enormous commercial opportunities
for the food and drug industries. The food and drug industries are the main markets where
GM products are being distributed. Human insulin was the first Genetically Engineered
drug, which was approved by the FDA in 1982. Yet another early application o f GE was
the human growth hormone. Perhaps the most successful application of GE technology is
Genetically Modified Organisms (GMO). Genetically modified food has been on the
market since the 1990s. Genetically modified soybeans, maize, and canola are basic
sources for the principle ingredients of GM food. Tomato, called FlavSavr, was the first
commercially grown GM food crop introduced by the company Calgene in 1992. The
product was available on the market in 1994. Consumers evaluated it poorly because of
its unpleasant flavor. The product was withdrawn from the market in 1997. However, it
was a “perfect” tomato for canning purposes because of the improved content o f solids.
Today the list of products that are “genetically modified” is very extensive: cotton,
com, sugar beet, wheat, tomato, potato, flax, squash, papaya, cantaloupe, soybean, rice,
and canola are examples (The full list and description o f these GM products can be found
at www.cfsan.fda.gov), (CFSAN). Over 40 countries on six continents are commercially
growing GM crops. The total surface area o f land cultivated with GMO has increased by
a factor o f 30 (from 4.2 million acres to 128 million acres) between 1996 and 2001. In
2004, the area was 200 million acres, two thirds o f which are in the USA (see Table 1,
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Appendix 1). There are four countries that ‘share’ 99% o f the land that is occupied by
GM crops: USA -68% , Argentina -22% , Canada - 6%, and China - 3%. It is estimated
that about 70% of products that are carried in American grocery stores contain GM
ingredients. Seventy five percent of all processed foods contain GM ingredients. Bt com,
soybeans designed to tolerate herbicides and insecticides, and canola are the leading GM
products. The USAD estimated that 38% o f all com and 80% of all soybeans planted in
2003 were genetically modified (Wikipedia).
Market opportunities for GM product are tremendous. Future applications include
bananas, vaccines against infectious diseases, fruit and nut trees that yield earlier, fish
that mature faster, etc. The interest in the research and development o f GM products
suggests that the market of these products will grow rapidly in the next decade.
Nonetheless, at this time GM technology is still at the early stage o f diffusion. There are
several barriers that prevent it from diffusing more rapidly. The main barriers are the
concerns of farmers, consumers, and environmental organizations and disagreements
between different countries about utilization of GM products.
3. B Market Structure and its Characteristics. Leading GM Companies
As stated, market opportunities for GM products are growing rapidly. As a result,
many new firms are trying to enter this market. There are about 27 established companies
in the territory of the US that commercially grow GM crops. The “Monsanto” company
of the state of Missouri is by far the largest producer o f GM products. The other four
leaders are “Dow Agro Sciences” of Illinois, “Calgene” of California, “AgroEvo” o f
North Carolina, and “Dupont Agricultural Products” o f Delaware.
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The market for GM products can be characterized as containing a high degree o f
monopolistic power and there are several barriers that can prevent a newcomer from
entering the industry. First of all, by the nature of the GE product, a firm will have to
invest into research and development of the future product or buy GE seeds or foods from
already established firms such as Monsanto. License and royalties used to obtain use o f
the technology increase firm’s fixed or sunk cost (depending on the nature of
technology). Second, there are governmental regulations that prevent a company from
starting production “on the spot” - prior testing has to be done on the safety o f a new
product. Third, there are negative attitudes o f some consumers, farmers, and
environmental organizations due to the lack o f agreement in the scientific circles about
the long-term effects of the GMOs on the environment and human health. Thus, a new
company has to be able to find a firm ground in order to establish a profitable business.
However, in the U.S. the absence o f labeling and the lack of proper information in the
U.S. media about GM products have left consumers uninformed about the potential
consequences o f genetic modification. For example, in a recent poll 70% o f the
Americans had never heard of Genetic Engineering or considered it as hybridization or
cross-pollination. Nevertheless, in U.S. the GM industry is thriving. According to the
National Center for Food and Agriculture Policy, GM crops created a net value increase
o f $ 1.5 billion to the food industry in 2001 (Kawar, 2003).
The U.S. market for Genetically Engineered products is peculiar. It has to be noted
that currently the food market consists of organic, conventional (produced using
pesticides and herbicides), and genetically altered products. Due to several factors, the
market for GM products merged with the conventional food market. For instance, US
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bio-engineered foods regulations do not distinguish between the conventional and
genetically engineered foods. Thus, unique GM products are being placed on the market
the same way as other products. Often the costs o f growing GE crops are a lot smaller
than the costs of growing conventional or organic crops. This is due to a genetic
technology that “codifies” needed information into the plant and, thus, certain
characteristics can be suppressed or magnified without extra cost (ex. plants with
resistance or tolerance to insects). No specific labeling is ascribed for such plants or
products that have some ingredients from them. This fact creates a challenge o f tracing
particular effects of the GM products on the food market itself. The same is true for
attempts to measure the magnitude of the GM food market. However, knowledge that
some markets (such as soybean, com, and wheat) exhibit a very high degree o f GM crops
(from 70-90%) permits some industry analysis. For example, four-firm concentration
ratios1 are presented in the Table 2.

Table 2. Concentration Ratios of the Top Agricultural Firms, 2001.
Com exports

Cargill-Continental Grain, ADM, Zen Noh
- 81%

Soybean crashing

(ADM, Cargill, Bunge, AGP) 80%

Soybean exports

(Cargill-Continental Grain, ADM, Zen
Noh) 65%

Flour milling

ADM/ConAgra/Cargi 11/General Mills/ 61%

Source: Howard P., Consolidation in Food and Agriculture: Implications for
Farmers & Consumers, The Natural Farmer Vol. 2, No. 68.
http://www.organicconsumers.org/2006/article_416.cfrn

1 The inconsistency was noted for the agricultural industry CR4: only three firms are cited in the
parentheses, when the rest of the source discuses four-firm concentration ratio.
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The concentration ratios are comparatively high. In general, economists believe
that a concentration ratio higher than 40% signifies an uncompetitive market (Gillian, T.
W.). There are several processes that accompany concentration: horizontal integration
(consolidation o f ownership within one stage o f the food system); vertical integration
(following up the whole process from production to distribution); and global expansion.
Companies can engage in formal or informal agreements to form alliances in order to
achieve higher profits. Cargill and Monsanto formed a cluster in which Monsanto has
been providing genetic material and seeds; Cargill has been involved in grain collection,
processing, meat production and processing. Kroger, the largest supermarket chain in the
US, is linked to this cluster through an agreement with Cargill. DuPont/ConAgra and
Novartis (Syngenta)/ADM have similar ties (Heffeman et al., 1999). Most of the large
players in the food market follow a strategy o f diversification - they produce both
Genetically Engineered and organic foods - that covers the entire market for consumer
products. However, it can be risky for business to be able to appeal to different consumer
groups, when some o f the groups have negative attitudes towards conventional products
and genetically modified foods and choose organics; and some might become distrustful
of quality o f the mainstay products as more and more organic foods are appearing on the
shelves o f the stores. For many companies the risk outweighed by the higher profits from
the increased GE crop yields and lower prices o f such crops.
As mentioned, vertical integration is quite common in the food industry. Companies
that practice GE solely penetrate production and retail markets, forcing out conventional
foods firms. Why is this the case, especially when the large food and agriculture firms are
not, per se, the leading GE companies? The answer to this question lies in the heart o f a
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seed industry. This is where true concentration of GM technology starts. The idea is that
Gene Kings like Monsanto, Dupont, Dow, and others cultivate GE seeds, patent them,
and sell to the farmers all over the world. Thus, through the retailer chain, more and more
GM products reach the consumer. In the USA, it is generally the case that if a certain
product does not have a “Certified Organic” stamp, it is likely to have one or more GE
ingredients (such as a soy component or GM bacteria). Table 3 presents the annual sales
in the seed industry for the year 2004.

Table 3. World Top 11 Seed Corporations 2004 (Sales; US millions)
1. Monsanto (US) + Seminis pro forma

6. Land O’ Lakes (US) $538

$2,803
2. Dupont/Pioneer (US) $2,600

7. Sakata (Japan) $416

3. Syngenta (Switzerland) $1,239

8. Bayer Crop Science (Germany) $387

4. Groupe Limagrain (France) $1,044

9. Taikii (Japan) $366

5. KWS AG (Germany) $622

10. DLF-Trifolium (Denmark) $320
11. Delta & Pine Land (US) $315

Source: ETC Group. (Sep/Oct. 2005). Globa Seed Industry Concentration - 2005.
Communique, Issue # 90. Retrieved from http://www.etcgroup.org/en/
At the top o f the list are three “Gene Giants” - Dupont, Monsanto, and Syngenta.
According to Phillips McDouglas Agriservice, Bayer and Dow attained sales on the
biotechnology market worth around $3,000 million in 2001 (Schmitt, 2002). The top ten
firms accounted for aggregate seed revenues of $7,000 million dollars in 2002. This is
approximately one third of the world commercial seed sales (ETC Group, 2005).

The concentration ratio for the largest four firms in the seed industry for 2004 is
2CR4=13.3%+12.4%+ 5.9%+5%=36.6 (Total worldwide seed market o f approximately

2 Four-firm concentration ratio is based on sales in million dollars for the year 2004.
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US$21,000 million per annum). Thus, four companies control 36.6% of the world’s
commercial seed market. Four companies control 49% of commercial soybean market.
So-called “non-merger merges” are highly common in the seed industry. In April 2002,
Dupont and Monsanto agreed to exchange their key patented agricultural technologies.
This agreement gave both Gene Giants cross-licenses for maize, canola, soybean
technologies, and also gene transformation technologies. Another trend among the
leading Gene companies is a reduction in the amount o f the conventional seeds and
pesticides that they carry. According to the Chemical Market Reporter, crop protection
chemicals and conventional seeds growth are declining at two percent, while GM seeds
are growing at 16 percent rate (Doris de Guzman, 2003). However, the decrease in the
chemicals for crops production does not signify that GE companies cut down on their
usage. On the contrary, they created crops that genetically “depend” on company’s
chemicals. Essentially, it represents a bundle and in some cases a tie-in (a particular
example will be discussed in the Section 3.C.). A study done by Northwest Science and
Environmental Policy Center concluded that over an eight-year period (1996-2003),
planting the commercial GM crops increased pesticide use by about 50 million pounds
(Benbrook, 2003). Thus, the amount of chemicals and seeds produced for conventional
crops decreases while those for GE industry increases.

In general, the industry for GM products is using a research and development
strategy to create an advantage over competitors to ensure future returns to their
investment. Leading company in the seed industry - Dupont - released 43 new com
hybrids in the 2003, 28 o f which are genetically modified. Syngenta allocated $170
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million dollars to biotech research, which is 30% of its total research and development
budget (Milmo, 2003).
Vertical integration is another very effective strategy o f GE companies. As
discussed, Cargill, Monsanto, and Kroger formed a cluster, where Monsanto has been
involved in research and development and has been supplying Cargill Corporation with
new technologies. Cargill is involved in grain and meat production and processing.
Kroger, in turn, is a countrywide retailer that carries meat that has been supplied by
Cargill. DuPont/ConAgra and Novartis (Syngenta)/ADM have a similar business
arrangement. Companies also practice package sales, bundling and tie-ins. Dupont seed
offers better interest rate on financing, depending on the choice of the farmer to buy
approved chemicals. These are products from Syngenta, Bayer/Aventis, and Dow. These
companies also practice bundling chemicals and other inputs with conventional seeds.
Thus, GE companies form vertical agreements (some conduct research, others produce,
and some distribute) and “share” sales amongst each other.
Chemical-Based Farming
The main industry-competitor is chemical-based farming. It uses pesticides to deal
with weed and insect problems. Most non-GM farming is carried out this way.
Proponents o f GM technology claim that the use o f chemicals is one o f the disadvantages
that genetic modification can successfully overcome, because it manages to create plants
that are herbicide tolerant and insect resistant. However, GE companies do not mention
that most of their GM seeds are designed to “work” with chemicals.
Organic Farming
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Another alternative industry is organic or ecological farming. We emphasize that it
implies not only the avoidance of chemicals, but it approaches farming holistically. It
concerns itself with rotation, selection o f tools, time o f planting and cultivation, and
internal drainage as ways of dealing with “weed problems.” Thus, organic farming tries
to “avoid the problem” by working with existing synergies rather than finding the way to
“solve” it. Organic farming is thought of as the most environment-friendly type of
farming. However, there are many opponents o f this technology that complain that it
takes too much land to grow crops. Today, organic products are not big competitors for
conventional and GM products. The amount of profit comprised from them is
comparatively small. Although, the market for organic products is growing rapidly as
more and more consumers discover the benefits of healthy and responsible living.
However, as it was noted before, most companies are trying to maximize their
efforts in pleasing the consumers; whether they produce, retail, or produce and retail both
GM and organic products.
3.

C Monsanto. Leading GE Company. Strategies and Development Landscape

It is known that “today, the top 10 seed companies control 30% o f the global seed
trade” (RAFI, 1998:13). Monsanto is definitely one o f the companies, which has been
aggressively trying to consolidate the market through formal and informal agreements.
The company was not in a “first mover advantage,” position when it entered the GM
market. However, it was able to gain a lot of the market power very fast. Since 1996,
Monsanto has invested 8.4 billion dollars in building up agreements and buying out
companies that have DNA codes databases, patents, procedures for cross-pollination, and
access to food, seed, and pharmaceutical markets. Monsanto makes connections all over
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the world. In particular, it is interested in the Brazilian soybean market (Brazil is the
second largest soybean producer). The interest o f the company is justified by the fact that
Monsanto holds a monopoly position in all GM soy technologies.
In 1996, Monsanto and Dekalb Genetics signed a ten-year research and
development agreement (Robertson, 1998: 325). This allows both companies to exchange
the licenses for com and soybean seeds. In 1997, Monsanto and Millennium
Pharmaceuticals signed a 218 million dollars partnership. The goal of this agreement is
for Millennium to transfer its technologies in genomics, gene sequencing, and
bioinformatics to Monsanto (Marshall, 1997: 1334). In 1998, Monsanto bought Cargill
Incorporated for 1.4 billion dollars. This purchase allowed Monsanto to have a leading
role in production and research facilities in 24 countries and access to sale and
distribution transactions of over 51 countries (Johnson, 1999:1). These are just few o f the
companies’ “super-deals.” However, the most interesting one was done in 1999 for 1.9
billion dollars with Delta and Pine Land Company. This firm had US patent #5723765
that controls plant gene expression. Among other “helpful” features, it patents the ability
of a plant to self-terminate after one-time crop is gathered. Therefore, there is no second
generation of seeds produced. The technology is called TPS (technology patent system).
This amazing technology ensures a good crop for a farmer and annual profit for
Monsanto. However, a farmer cannot save the seed for the next year. Monsanto addressed
this issue in a press statement explaining that each farmer should respect the amount o f
research that was put into the development o f this amazing product and should not try to
save the seeds. Few companies were able to come up with a product like this that “keeps
on giving.”
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Another area where Monsanto affects the whole industry is the company’s
chemical production. The firm was able to successfully develop a seed that actually
reinforces sales of the Monsanto’s brand o f a weed killer - Round Up. Round Up Ready
gene trait tolerant to the company’s weed killer is now growing on more than 40 million
hectares worldwide. Thus, Monsanto have created a perfect complement or a bundle: a
trait and a weed-killer. Monsanto does not stop on what it’s already achieved, it will
allocate 80 percent of its research and development budget on biotechnology (SeedQuest
News, 2003).

All of the strategies described above signify a strong willingness o f the company to
concentrate the GE market and possibly establish dominance on it. To summarize
Monsanto’s company makes large, diverse investments in research and development. In
year 2002, its sales for the seed industry comprised $1.6 billion (second largest company
on the market); agrochemical industry - $3,088 billion (third largest company) (Agro
World, 2003); its division on the food and beverage processing industry Cargill Inc. sales
were $21.5 billion dollars (seventh largest company on the market). In 2004, Cargill
moved to a fifth position in the world; its sales for this year comprised $27,260 million
dollars (Food Engineering, 2003).
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4. Risks, Costs and Benefits of GM Technology
4.

A Genetic Modification versus Chemical-based and Organic Farming

GM technology has a lot of potential, but it carries certain risks as well.
Recombinant DNA technology allows imposing certain characteristics on a given plant or
organism. For example, a plant can develop herbicide tolerance and insect resistance.
This is supposed to benefit the farmer by reducing production costs. It also has an indirect
effect on the consumer by making the product “free of chemicals” (some, however, argue
with this opinion). There is a reduction in greenhouse gas emissions from decreased fuel
use. Also, GM farming reduces the need for plowing and improves conservation tillage. It
was estimated that this reduction was equivalent to eliminating ten billion kilograms o f
carbon dioxide from the atmosphere in 2004.
However, these impressive improvements can advantage GM farming only when
compared to chemical-based farming. Indeed, the first wave of biotechnology
concentrated its research on how to deal with the issues o f weed and insect control. The
solution was to use herbicides and insecticides. In 1995, herbicides accounted for 64% o f
total biocide sales in the US, with com and soybean sharing 65% o f these. The use o f
insecticides increased by 20% between 1986 and 1995. In the past three decades, the
number of insecticide treatments increased from one to six per acre. Consequently,
farmers’ costs have grown tremendously. The cost of “seed plus chemicals” increased by
50% between 1975 and 1997 (Benbrook, 1996). The question arises: why is there a need
for more chemicals? The answer is that traditional chemicals do not work any more. GM
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technology offers the alternative. However, some scientists argue that genetic engineering
not only does not solve the problem that chemical-based farming poses, but even worsens
it. E. Ann Clark, Associate Professor in the Department o f Plant Agriculture (University
of Guelph, Ontario, Canada), confirms, “in addition to stimulating outbreaks of
secondary pests, GE crops screen for and promote expansion o f tolerant and resistant
biotypes and demand ever higher and more targeted biocide use” (Clark, A. E.) Do GE
crops reduce chemical use? The answer can be obtained from the information provided
by the USDA (Table 4).

Table 4. Insecticide or Herbicide Use for GE Corps
___________ /~ < r ? ______ _ / 1 n m

— ua
GE versus non-GE crops (1997 only)
Insecticide use

Herbicide use

I

a
„+ c o / 1
Acre
treatment3 at
5% level significance
Lower in one of one region for Bt com
(from 0.07 to 0.00)

Lower in two o f three regions for target
pests of Bt cotton
Lower in zero of one region for HT com
Lower in three o f five regions for HT soy

Lower in one o f two regions for HT cotton
Source: Adapted ERS-USDA Economic Research Service-United States Department o f
Agriculture. (1999) Genetically Engineered Crops fo r Pest Management.
According to the information in Table 4, in the year 1997 insecticide use for target
pests was reduced in three out four regions for Bt com and Bt cotton combined. In the
same year, herbicide use for target pests for HT com, HT soy, and HT cotton was
reduced in four out of eight regions. However, for non-target pests, growing a GE crop
(Bt cotton) increased insecticide use in one out o f three regions and modestly increased
the overall dependence on insecticides (Table 5).

3 An acre treatment is the number of different pesticides applied per acre times the number of repeat
applications
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Table 5. Insecticide Use Patterns for Bt and non-Bt Cotton in Three
Regions in 1997 ________________ ________________ ___________
Bt target pests

All other pests

Bt

Non Bt

Bt

Non-Bt

Difference (%)

Mississippi portal

0.54

1.27

8.19

4.43

+85

Southern seaboard

0.31

1.95

2.19

1.37

+60

Fruitful rim

0.63

0.60

3.19

4.14

-23

Mean

0.49

1.27

4.52

3.31

For Bt cotton, 5.01 acre treatment; non-Bt cotton, 4.58 acre
treatment
Source: ERS-USDA Economic Research Service-United States Department of
Agriculture. (1999) Genetically Engineered Crops fo r Pest Management.
Sum

As it can be seen from Table 5, growing Bt cotton reduced insecticide use for Bt
target pests (that is why Bt com was created), but moderately increased total insecticide
use by about 9% (5.01 versus 4.58 acre treatments). Thus, proponents of GM technology
do not consider the fact that non-targeted species will multiply as the number o f targeted
species decreases, which in at the end will cause the application o f more pesticides.
Therefore, it is arguable that GE crops reduce the amount o f biocides.

Organic farming, or any other ecologically based farming, should be considered
before GM and chemical-based farming because o f its sizable advantages. Opponents o f
organic farming claim that it does not give more yield than other types of farming, unless,
there is a larger “base” - more land. And this, they say, can have potentially harmful
effects on marginal land. However, striving for a large yield does not give an advantage
to farmers, nor does it benefit consumers and the environment. For instance, Canadian
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farmers are left with only 10% of value from what they grow. Thus, around 75% is going
to the seed trade and chemical purchases. Moreover, the more yield there is, the more
crops are in supply. Since farmers are on an inelastic market, they have to sell their crops
for less, consequently getting less marginal profit. On the other hand, consumers are
paying high prices due to processing, transportation, and retail costs. The actual product
(wheat, com, etc.) that they are receiving comprises the lowest proportion of their
disposable income. On contrary, organic farming with its “smaller yields” would not
lower the profit for farmers and rise the price for consumers. As it was discussed earlier,
the environmental effects of GE and chemical-based farming are a lot worse than the
effects of organic farming.

Proponents of GM technology argue that an ever-growing population needs more
and more food; therefore, farming should seek to produce larger yields. Genetic
engineering, they affirm, is the perfect answer to this. It “promises” to engineer plants
that are able to withstand harsh environments and have long shelf lives. However,
according to the United Nations Food and Agriculture Organization (UNFAO) report, the
production o f food can meet the global demand without GM crops in the year 2030 (Food
and Agriculture Organization of the United Nations, 2000).

Another argument that is presented in favor of GM foods is that it will be able to
eradicate poverty and malnutrition in Africa and other developing countries. However,
the main problems causing hunger in those countries have a political nature (wars, poor
land management, financial dependency on the IMF, large debts, etc.) and not o f the
technological sort. Also, there are economic implications: globalization and the free
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markets attract big corporations and their investments to these countries. The
consequences of this for the native population is very unpleasant: fishing communities
are driven out o f business, farmers are left without their “bread” and forced to find jobs in
urban areas, even public goods like water are privatized (Wee, V. et al.). Thus, as we can
see, poverty and hunger are not the foremost problems of technology o f production. They
are the problems with regulating the world income distribution, dealing with political
powers, and simply acknowledging ideas such as human rights and equality. Therefore,
the argument about the ability of GM technology to “save the world” from hunger and
famine has to be reevaluated.

4. B Health Effects of Genetic Modification

The health effects of GMF are the greatest area o f concern. Many scientists around
the world confirm that there is a lot of uncertainty of the real effects of GM products on
human health. They assert that a lot of research has to be done before GM technology is
allowed to fully invade the market. Traceability o f the effects of GM foods on human
health is prevented because of the absence o f proper segregation and labeling (the
labeling policies will be extensively discussed in the Section 5.

Showa Denlco Case

There is evidence o f serious health effects o f GM foods. In 1988, the company
Showa Denko switched from its traditional way o f producing an I-tryptophan supplement
to a GE approach. The product was a staple in health food stores and was considered a
safe treatment for insomnia - “the ingredient in warm milk that brings on sleepiness.”

21

The procedure was carried out in the following way: a “gene for I-tryptophan was spliced
into bacterial DNA to synthesize a new production strain (Strain V). The bacteria were
grown in fermentation vats, from which I-tryptophan was extracted and purified.” Since
the product was considered “safe” for many years, consumers pursued their purchases o f
the new medicine. However, within a month ‘Strain V ’ killed thirty seven people, 1535
people were permanently and severely disabled with “eosinophilia myalgia syndrome,”
and five thousand were temporarily disabled. It was claimed that the product was 99.6%
pure, but the cross contaminants (one being EBT) were enough to kill or disable a person.
Although the tragedy occurred right after the company switched to the Strain V, the real
cause is still unclear because Showa Denko destroyed all the evidence, including the
strain, before the investigation team of the FDA arrived. Showa Denko made official
claims that the cause o f the accident was due to a reduction in the amount o f activated
carbon. However, the company’s lawyers justified that it happened before without undue
effects (Boyens, 1999).

Food-born Illnesses

Another area of concern is the ever-increasing number o f food-born illnesses since
1994 (the year of the appearance of GMF on the market). According to the report Foodrelated illnesses and death in the United States, released in 1999, food-borne diseases
cause approximately 76 million illnesses, 325,000 hospitalizations and 5,000 deaths in
the US each year (Mead et al., 1999). Known pathogens account for 19% percent o f foodborn illnesses. This means that unknown agents account for approximately 81% o f foodborn illnesses and hospitalizations and 64% of deaths. The number o f food borne
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illnesses more than doubled in the past decade (Council o f Agriculture Science and
Technology, 1994). In 1994, the figures were between 6.5 and 33 million illnesses per
year. In terms of incidence, the increase is from 25 to 130 cases per thousand inhabitants
in 1994, to 278 per thousand in 1999. What might cause such an increase?

A one-year Swedish study might bring some light on this issue. It took place
between 1998 and 1999 in the Municipality of Uppsala o f 186,000 inhabitants (Lindqvist
et al., 2001). Five hundred and fifteen cases were documented and 268 incidents were
recorded (twenty eight incidents per thousand citizens). This is comparable with the US
food-born illnesses records for 1994. Consequently, this means that the incidents in the
US increased tenfold in 1999 compared to 1994 and tenfold compared to that in Sweden.
Some other aspects of the Swedish study are comparable to those o f the US. The
etiological agent was unknown in 79% of the cases in Sweden (81% in the US). The
difference appeared in terms of known etiological agents. In Sweden, “bacteria were
found to cause 10% of the incidents and 25% of the documented cases, compared with
13% of the cases in the US. Viruses, on the other hand, caused only 9% of both the
incidents and documented cases in Sweden compared with 80% o f cases in the US.”

The Swedish study suggests that incidents of the food-born illnesses are comparable
to those of the US in 1994, which is not strange because both countries had similar food
hygiene. However, the results are vastly different for 1999. The United States
experienced an increase in food-bom illnesses o f up to ten fold. This fact has to be
thoroughly researched. Notably, the amount of GM food on the American market grew
tremendously since 1994. The proponents o f GE technology insist that it does not bring
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any harm but the “health authorities should be on the lookout for new viruses and
bacteria that could evolve by the horizontal transfer and recombination o f viral and
bacterial genes in the genetically engineered crops” (Ryan et al., 2003).

Antibiotic Resistance

Another area of concern with GM products is antibiotic resistance. In order to
indicate that organism was successfully engineered, genetic engineers include antibiotic
resistance genes as ‘posts’ nearly in every genetic engineered organism. In the May 1999
report on GMF, the British Medical Association stated, “There should be a ban on the use
o f antibiotic resistance marker genes in GM food, as the risk to human health from
antibiotic resistance developing in microorganisms is one of the major public health
threats that will be faced in the 21st century”(British Medical Association, 1999). The
American Medical Association expressed the same concern.

New Allergies

Yet another problem is that GM products might bring a new wave o f allergies and
toxins as they introduce “foreign” elements to the human body. Also, GE technology can
create danger for which it will be difficult to test. Inserted into the target organism,
transgenes can affect (e.g. alter) traits, whether they were intended to be altered or not.
Notably, this is not considered in the safety protocols used in the US and Canada
(Benbrook, 1999).
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Laboratory Test Results

The most recent study on the effects o f GM soy on rats in the laboratory conditions
was done by the Institute of Higher Nervous activity and Neurophysiology, Russian
Academy o f Science, in 2005 (Ermakova, 2005). The goal of the experiment was to
evaluate the influence o f the GM Roundup Ready (RR-soy with the transgene CP4
EPSPS; 40.3.2 line, Monsanto) on the Wistar rats. Female group of rats was divided into
three groups: those who were fed with laboratory chow plus RR-soy flour (5 to 7
grams/rat/day) before and during mating, during pregnancy and lactation; those who were
fed with chow plus the same amounts of the traditional soy variety (arcon SJ 91-330,
ADM; which is similar in nutritional value and composition to the RR-soy); and those
that were given just the laboratory chow without any supplementation (the control
group). Physiological conditions, the behavior, and the mortality were monitored,
recorded, and analyzed all through the experiment. From the 15 females in the
experiment, eleven gave birth to a total o f 132 pups. In the ‘Traditional’ group tree out of
six females gave birth to 33 rat pups. In the GM group four out of six females brought
forth 45 pups. In the control group the number o f newborn pups was 44.

The results of the experiment were quite devastating. By the end o f the third week
o f lactation, twenty-five out of forty five pups in the GM-group died. Only three pups out
of thirty-three in the ‘Traditional’ group have died (Table 6).
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Table 6. Mortality of Rat Pups by the End of the 3rd Week of Lactation
Number of pups

Number of dead

Dead pups/total

bom

pups

bom (%)

Positive control

44

3 (p=0,000118)4

6.8%

Trad. Soya

33

3 (p=0,000103)4

9%

Groups

55.6%
25
GM-soy
45
Source: Ermakova, I. V. (2005). Influence o f Genetically Modified-SOYA on the BirthWeight and Survival o f Rat Pups: Preliminary Study. Institute of Higher Nervous
Activity and Neurophysiology, Russian Academy of Science (RAS). Retrieved from
www.mindfirlly.org.
Every four o f the females in the GM group had from 46 to 64 percent o f their litter
dead by the end o f the third week o f lactation (see Table 7, Appendix 2). Considerable
differences were noted in the weights of GM-fed pups compared to the other two groups
(RR-soy group had pups considerably smaller that those of other groups). The difference
in absolute weights is especially pronounced for livers, kidneys, and hearts of the GM-fed
rats. The conductors o f the experiments concluded that there are two possible
explanations for such negative effects of the GM soya. First, the effects can be due to the
insertion of the foreign genes and the following transformation and penetration into the
cells of the fetus. Also, it can be attributed to “the instability of gene constructs” for GMsoy (Windels et al., 2001). Second, high mortality can be attributed to the accretion of the
residues from the Roundup Ready in the soy. Scientists refuted the second explanation
due to the fact that no mortality was observed for mothers and survived pups, which were
continuously fed with the GM soy. Thus, the negative effects were found to be due to the
first reason.

4 Compared to the GM-soy flour supplemented group
4 Identical to the previous footnote
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These are alarming findings and conclusions. Since, on the one hand, the size o f the
GM market is quite large (and still growing) and, on the other hand, there is no adequate
information for consumers, scientific society has to take a step and conduct a series o f
independent researches. Moreover, if more studies o f the sort will come up with the same
results, there will be not only large economic impacts but also social, environmental, and
health-related.

4. C Environmental Effects of Genetic Modification

Concerns about Genetic Modification are not limited to health issues. There are also
environmental concerns. Some of them were discussed at the beginning o f the section 4
of the present paper (Tables 4 and 5). Others include soil and wildlife issues.

The Max Planck Institute for Soil Microbiology in Germany conducted research on
genetically modified potatoes (Lukow et al., 2000). The findings include the fact that
these potatoes change bacterial communities in the soil. These results indicate the strong
need for further investigation of the long-term consequences o f such changes; especially
considering the fact that even smallest changes in microbial ecology can have devastating
long-term effects on soil fertility, the availability of nutrients, and even on the promotion
o f pathogens such as nematodes, fungi, and harmful bacteria.

Also, biotechnology seems to be “against” biodiversity. It tries to deal with weed
and insect problems by creating plants resistant to them. However, GM is not concerned
with the side effects - the extinction of certain types o f grass and insects. It is well known
that there are food chains in nature and by reducing species GE affects wildlife in
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general. The study on the extinction of certain types of field birds in England that was
presented in 2002 to the Royal Society is one such case (The Royal Society, 2002).

One of the serious concerns that genetic modification caused in the scientific and
agricultural circuits is the question of coexistence. Is it possible for GM and non-GM
crops to exist and do not diminish the vital space and development of each other? Several
concerns exist in regards to this question. First one is cross-contamination of pollen from
GE plants to non-GE plants. This concern is very viable as o f today. Hundreds o f cases
were registered when non-GM crop was found to have traces of their GM counterparts.
Moreover, cross-contamination can lead to creation of super-weeds and thus will reduce
the variety o f non-targeted, area-based weeds. Second type o f concern is GM seed
dispersal during transportation, which basically leads to the same consequences as a first
one. Third, almost all agricultural systems that grow both GM and non-GM crops do not
have a segregate system of production and utilization o f those crops. Thus, admixture o f
the residue seeds occurs during the sifting and sorting process o f these two types of crops.
Fourth concern is the fast evolution of resistance o f insect pests such as Lepidoptera to
Bt. Fifth, is “accumulation of the insecticidal Bt toxin, which remains active in the soil
after the crop is plowed under and binds tightly to clays and humic acids” (Altieri, 2005).
Sixth, Unexpected effects on non-target herbivorous insects (e.g. monarch butterflies)
through deposition of transgenic pollen on foliage o f surrounding wild vegetation (Losey
et al., 1999). Seventh concern is gene transfer that can lead to the creation of the new
pathogenic organisms. All listed above concerns put strong doubt on the possibility o f
coexistence between GM and non-GM crops.
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GE crops affect both conventional and organic agriculture. In fact, the latter suffers
from both conventional (since it does not recognize the use o f pesticides and herbicides)
and GM agriculture (since uses only natural or organic ways of selection, cultivation, and
production). Above ethical and economical there are agro-ecological basis o f
incompatibility between organic and GM systems o f agriculture (see Table 9).

Table 9. Characteristics of Organic Farming and Genetically Modified
Based Agriculture
______________________ ____________________
Characteristics
Petroleum dependency
Labor requirements
Management intensity
Intensity o f tillage
Plant diversity
Crop varieties

Source of seeds
Integration of crop and
livestock
Insect pests
Insect management

Weed management

Biotech
High
Low, hired
High
High except in no till
systems
Low
Genetically Modified,
homogeneous, one variety
over large areas
Multinational corporations,
all purchased, patented
None
Very unpredictable
Insect-resistant crops

Herbicide-resistant crops,
chemical, tillage
Chemical, vertical
resistance

Organic
Medium
Medium, family or hired
Low-medium
Low (no till w/o herbicides)
to medium
Medium to high
Hybrid or open pollinated,
variety mixture
Purchased form small seed
companies, some saved
Little (use o f manure) to
crop-livestock mixture
Unpredictable
Integrated pest
management, bio
pesticides, bio-control,
habitat management
Cultural control, rotations

Antagonists, horizontal
resistance, multiline
cultivars
Chemical, fertilizers applied Microbial bio-fertilizers,
Plant nutrition
organic fertilizers, semi
in pulses, open system
open system
Sprinkler and drip
Large
scale
irrigation
Water management
irrigation, water-saving
systems
Source: Altieri, M. The Myth of Coexistence: Why Transgenic Crops Are Not
Compatible With Agro-ecologically Based Systems o f Production, Bulletin o f Science,
Technology & Society, 25, 4, 2005, pp.361-371

Disease management
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4. D Social Problems

Together with health and environmental problems, there are, also, social problems.
Some scientists emphasize the fact that research on GM products is strictly commercially
supported. Large corporations are the leading institutions that support research in the GE
sphere, expecting positive results in return. Also, most o f the graduate programs in
agriculture suggest studying mostly molecular genetics and related disciplines. Research
and studies on “conventional agriculture” are not supported by the departments and do
not get a lot of financial help from private companies or the government. This raises the
question of scientific integrity and the reliability o f GE and GM research (especially in
the USA) (Clark, A. E.).

In spite o f the controversies about GM technology, there are parties that benefit
from genetic engineering. These are the government and companies that supply GM
products. There is an obvious reason why corporations benefit - profit. On the other hand,
the position of the government is not all that clear. Perhaps, it is motivated by the benefits
from international trade, ideas about “feeding the world,” and a desire to bring benefits to
domestic farmers, although, it is not always clear who benefits from trade in GM
products. Moreover, there is little public evidence of existence o f societal benefits from
GM products to date. This can be based on the following: disregarding health and
environmental concerns and despite the fact that GM allows to reduce production costs,
increase agricultural productivity, and eventually increase the amount of the food supply
non o f these benefits were reflected in the price o f the goods for consumers. First o f all,
there was never a distinction between the conventional products and the GE products.

30

Thus, the benefit of a “cheaper” technology was hidden from the consumers. Thus, they
are still paying the same prices for the conventional and newly introduced GM products.
Only proper labeling o f the GM products and consequent reduction in prices o f these
goods are able to determine societal benefits.
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5. Global Overlook o f Policies on GM Products

Most countries consider two important policy approaches for addressing issues
surrounding GM foods. One of the areas includes the standards for regulating and testing
for food safety. The other encompasses labeling policies and the traceability o f GM
products. The approach for dealing with these issues is different in every country. The
United States, for instance, does not require labeling o f GM products. The regulation o f
safety and testing of GM as well as non-GM foods is under the jurisdiction of the Food
and Drug Administration (FDA). The FDA created a special service - the Biotech
Regulatory Service (BRS) - that regulates field and product testing, movements, and the
importing o f GMOs. Their reports are now publicly available on the BRS web site
(Biotech Regulatory Service). Although GM foods do not require labeling, prior testing is
an essential part o f the procedure before the product is put into the market. Companies
must submit documentation on the safety of their products to FDA and then wait for
approval. The companies themselves test GM products according to the “FDA Statement
of Policy: Foods Derived from New Plant Varieties.” This raises a question o f accuracy
of such testing. Proponents o f such a policy argue that the results o f testing are closely
monitored; therefore, it is in the best interest o f the companies to make sure that their
products are safe.

The second area o f the policies for GM products is labeling. According to Section
403(i) of the Federal Food, Drug, and Cosmetic Act, a producer is required to reveal on a
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label, “all facts that are material with respect to consequences which may result from
use.” This suggests that if the food derived from a new plant variety differs from its
counterpart in safety or usage, then it should be labeled accordingly. But most GE foods
do not require labeling, because the FDA does not consider the method o f production o f
the new plant variety to be a “material fact”. The regulation of the crops engineered with
pesticide protein becomes responsibility o f the EPA. Despite this kind of policy,
American consumers do not seem to be against GM foods; rather they call upon the
authorities to present more thorough research on products safety.

On the other hand, EU consumers have a less liberal idea about Genetically
Modified food. They require strict labeling and segregation o f these foods on the market.
Since April of 1998 till the end of 2002, the EU banned all GM foods (GMO Compass,
2006). After that, it had a policy to label all of the GE crops if they contain more than
0.5% of GM ingredients. In 2004, the EU developed a new set o f rules for the traceability
and labeling of GMFs. It requires labeling o f highly refined products (oil and com syrup)
produced from GM components, even though the recombinant DNA or protein cannot be
traced. However, labeling rules do not apply to products of microbial genetic
engineering; thus, GM cheese does not require labeling. On July 13, 2006, the European
Commission announced its current ban of GM crops illegal and is going to come up with
a new set of regulations for labeling and traceability o f GE imports. Environmental
groups accord this move of the UC with the informal threat of the US to the WTO about
unfair trade. As for today, the European Commission admitted a range o f GM foods and
crops despite having serious concerns about their safety for human consumption and
environment. The reports released by the EC stated, “there simply is no way of
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ascertaining whether the introduction of GM products has had any other effect on human
health,” and, “no unique, absolute, scientific cut off threshold available to decide whether
a GM products safe or not” (Daily Telegraph, 2006).

Japan maintains labeling of the GM products by the European standard. In Canada,
labeling is not currently required. China is currently the largest producer of GM cotton.
However, other GE crops such as tomatoes, pimentos, species o f the morning glory and
rice are grown in China. In March 2002, China presented new biosafety rules that
demand strict testing and labeling of GM products. Currently, many Chinese institutions
are working on developing and testing GE products.

Developing countries of the African, Asian, and Pacific regions have become more
receptive to GE technology. Agricultural officials from these countries take training
programs on GMO at the American Agriculture Department. At the same time, the US
industry groups provide financial and technical support o f GE research to the developing
nations.
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6. Integrating Socio-Economic Factors into Bio-Safety Decisions in the Agricultural
Sector

Agriculture is a vital sector in many country’s economies. It is especially
applicable in developing countries, where the agricultural sector is responsible for a large
percentage o f income and number of jobs. Thus, biotechnology has the potential to
provide better living and sustainable growth in these countries. Unfortunately, the process
of implementation o f the biotechnology is a multi-faceted process and, thus, it affects not
only secluded groups o f people but also society as a whole. Because o f its potential risks
reliance on GM foods has to be evaluated from many perspectives. The interests of a
wider range of groups and entities should be considered along with those of the
consumers and producers of the GE products. In this paper, we discussed possible health,
environmental, and social costs and benefits o f genetic engineering. This section
concentrates on the socio-economic implications o f the biotechnology. It elaborates on
such issues as distribution of wealth, involvement o f the public research and development
into biotechnology, labor markets, global markets, competition, organic agriculture,
intellectual property rights, and public opinion, religious, and cultural concerns.

6. A Distribution o f Wealth

Distribution of wealth is one of the factors that has to be considered in the light o f
the GE technology. One of the most vital questions o f today is finding ways to alleviate
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poverty. There are two approaches of doing so; the first is to increase food production.
The second is to increase per capita incomes and thus enabling people to buy more goods.
Biotechnology seems to address both approaches (Royal Society o f London, etc., 2000).
Economic studies during this past decade of GE implementation show that such
technology indeed increased wealth significantly worldwide. For instance, Runge and
Ryan in their 2004 study found that during the period o f 2003-2004, the total value o f the
transgenic crops planted in five leading “GM countries” was forty four billion US dollars.
The Australian Bureau of Agriculture and Resource Economics estimated that GE crop
implementation during the next ten years would generate 210.3 billion aggregate annual
GNP increase worldwide. The numbers are impressive, but the question rises o f who is
the primary receiver of that wealth? Is it poor and needy? Concerns exist that benefactors
are going to be farmers in the developed countries and not in the developing; big
corporations involved in design of the GM crops and not the farmers and consumers; and
within the country it will be large farmers benefiting more than small farmers.

The concern that biotechnology benefits richer farmers and passes by poorer is
based on the variety of traits that are currently in use. Most o f them provide pesticide
tolerance and herbicide resistance. Although they are beneficial to some (richer farmers),
crops with these traits do not address the needs o f the farmers in poor countries (such as
heat resistance, water retention, drought and saline soils resistance, and enhanced
nutrition). In 1999, a study by Falck-Zepeda et al. was done for Roundup Ready
soybeans concluding that the benefit breakdown between GE companies, farmers, and
consumers is heavily leaning on the side of the companies and farmers. Thus, 48 percent
o f the wealth created by the adoption of that crop was received by the US farmers,
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Monsanto received 22 percent, seed companies received 9 percent, non-US consumers
received 13 percent, and US consumers benefited 8 percent. The data for a third concern
(large farmers versus small farmers) appears to vary amongst different countries. A
recent study in China found that small farmers received a larger increase in yields than
large-scale farmers. However, this was not true for the US. In fact, in the US GM crops
often don’t yield as much as non-GM crops, and in some cases profits even declined
(Femandez-Comejo et al., 2002 and Duffy, 2001).

6. B Public Sector Research and Development

The lack of public sector research and development is another area o f concern
when looking at the biotechnology. The prevailing majority o f the research for the
development of the GE crops is currently conducted through the private sector. Some
analysts site it as a glaring failure of the public institution to produce unbiased results.
They argue that “positive” conclusions of such private studies are tailored for specific
requirements of the interested party (usually the producer o f the GM crops or seeds).
They also site the fact that leading GE companies tend not to collaborate with the
research institutions; they simply buy them out (see sections 3. B. and 3. C. of this paper).
Moreover, the absence of the public research and therefore public ownership created a
favorable environment for greater concentration o f market power and formation of the
monopolies (e.g. Monsanto in the US). The example o f China had shown that these
problems could be possibly avoided by involving public research sector and
development. The Chinese Academy of Agricultural Science had introduced a homedeveloped sort of Bt cotton (currently Monsanto corporation offers comparable type of
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crop). No studies were conducted to evaluate the effects of the presence of the publicly
produced GM crop on the distribution of benefits. However, it is quite clear that this kind
of competition would not allow for Monsanto to monopolize the market and possibly
reduce the seed prices for farmers (Eaton et al., 2003). Thus, a strong recommendation
can be made for inclusion of the public sector research and development into overall
development process of the new GE crops.

6. C Labor Markets

The development o f the GM crops can affect labor demand. It can both harm and
help in solving some of the labor issues globally. For instance, in places such as some
parts of Africa where diseases wipe out or reduce the work-years of most of the working
population, GM crops can solve the problem of undersupply (Nuffield Council, 2004).
Biotechnology would be useful for growers who are trying to cut down on labor demand
(e.g. insect resistant crops supposedly reduce the labor required to spray pests against
insects). However, in Asia where the level of mechanization is low and the amount o f
working population is high, the implementation o f the GE laborsaving crops can be
devastating. It can ruin the livelihoods o f thousands of people. The effect of the increase
in the amount o f these crops should not be discounted for the labor market in general.
Another recommendation is to conduct studies targeted on this issue.

6. D Global Markets

Global markets and trade patterns is another area o f socio-economic concern
regarding biotechnology. Attitudes, preferences, and tastes of the consumers define
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which crops are imported and which are not. Thus, the benefits or profitability from a
certain GM crop depends on the level of adoption to the whole idea o f biotechnology. A
study conducted by Anderson et al. in 2001, concluded that trade patterns (e.g. open trade
vs. a ban on certain imports) define how many benefits a country will enjoy from
adopting GM crops given the trade policies o f its trading partners (Anderson et al., 2001).
Specifically, if one of the trade partners refuses to import GM products on the basis o f the
consumer preference, a country-producer of such a product will encounter trade loss (e.g.
US and European Union). Disregarding the health and environmental concerns, according
to Anderson’s model overall benefits can increase if trade partners engage in GM crops
production or importation. For instance, consumers can benefit from the reduction in
prices; however, farmers may lose their profits due to the same factor.

The Anderson et al. study also concluded that countries that adopt a strategy o f
diverse production (e.g. GM products and non-GM products) will have an advantage in
international trade. In order to lead this kind o f strategy, a country would have to
establish an effective system o f segregation - labeling and separate production o f GM
and non-GM products. One of the downfalls will be an increase in the prices consumers
pay. It was estimated that for Canada and the US, the production cost increase can be
anywhere from fifteen to fifty percent and retail prices can increase by nine to ten percent
(Paarlberg, 2002). Based on this information, a recommendation can be made for the
governments to obtain relevant information on crops produced domestically, to collect
information on their GM match produced abroad, to define the direction o f exports of
such crops and the consumer attitudes toward GM products on these markets. Lack of
such information can create unfavorable trade conditions for the whole industry. Thus, in
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2004, several European companies discovered that their suppliers from Thailand were
illegally growing GM papaya. Some N G O ’s, including Greenpeace, blamed the
“leakage” of seeds on to the Department o f Agriculture research station in Thailand. The
seeds were not destined for commercial planting. After investigation, the government
declared that it would destroy all the papaya trees that were contaminated. Nevertheless,
EU companies stopped all imports of all canned fruit from Thailand in fear o f
contamination from GM papaya. Evidently, governments should take steps in clarifying
trade policies on GM products, and, since a favorable degree of certainty is still not
achieved, press the global communities for a distinct segregation and labeling o f such
products.

6. E Competition

One o f the other socio-economic factors that have to be considered is competition.
Rising competition on the agricultural markets is especially a characteristic of the
developing countries. Some o f them were among the first pioneers to adopt GM
technology (e.g. Philippines); however, some were not but felt pressure to do so based on
their perception of increasing global demand for the GM technology. In the end, these
countries were afraid o f being in economic disadvantage before their neighbors. In 2004,
the Prime Minister of Thailand suggested lifting the ban on growing GMOs. He believed
that failure to do so would mean that Thailand would “miss this scientific train and lose
out in the world” (Thailand May Overtake, 2004). However, the Cabinet did not support
the Minister’s thinking.
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Research and development and introduction of the new GM traits that can adapt
the crop to certain climatic conditions may cause major shifts in the world’s markets.
Thus, markets that are historically responsible for production of cinnamon and coconut
milk (mostly produced in the developing Asian countries) may lose their competitive
advantage since their counterparts in the developed world will be able to produce these
goods domestically. The same is for reverse products - crops that were produced only in
developed parts of the world now can be produced in the developing nations. The
estimation of such shifts will present an enormous challenge for economic analysts. The
government of each country should consider the costs and benefits o f these changes.
Moreover, the importance of public research and development can be called in help.

6. F Organic Agriculture

Organic agriculture is another area o f socio-economic concern. It is widely known
that this production system excludes the traditional way o f farming and the GM
technology. The rapid rate of growth of the GM industry presents a huge challenge for
the sustainable development of the organic industry. “Contamination” and the irreversible
mix of GM crops with organics and conventional crops is today’s biggest challenge. It
not only leads the organic farmers to enormous losses but also destroys the consumers’
confidence in the products they buy, recognizing the fact that the regulations concerning
the cases o f contamination are being treated differently in different countries. According
to the USDA regulations, as of 2000 organic farmers do not necessarily lose their license
if their products are found to have GMOs mixed with their organic produce.
Contamination of the organic crops by their GM counterparts is a growing problem that
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happens mainly through cross-pollination. For instance, Terra Prima, organic company
from Wisconsin, encountered losses due to the recall o f the 87,000 bags of tortilla chips
that were found to have GM com. As o f today, the coexistence between GM and organic
farming is highly problematic (more careful discussion was conducted in Section 4.C.).
The possibility o f the pest resistance to the Bt toxin (natural organic pesticide) is another
area o f concern for organic farmers. Pest resistance might occur due to the high presence
of this toxin in GE Bt crops (Altieri, 1999).

6. G Intellectual Property Rights

Another socio-economic factor to be considered with regard to GM technology is
the question of intellectual property rights (IPRs). In some developed countries, which
are leaders of the GM production, patenting is widely applied as a practice of protecting
the developer IPRs. This often implies that anybody on the territory of this country
wishing to use that technology has to pay a “technology fee” and sign a contract, stating
that no attempts will be made to save, replant, or sell the seed. Companies justify this
practice by the fact that the fee goes into covering the R&D costs. This practice might
jeopardize a historical tradition of the farming community, where seeds are saved,
selected, and shared amongst the farmers o f the community. It was the primary source o f
innovation and preservation of seeds and new types of crops for centuries. In many
farming communities, it is also a way o f reducing the production costs. The prevalence o f
the GM technology is likely to stop this practice and make farmers more and more
dependant on big seed corporations (e.g. Monsanto, Syngenta, Dow, etc.). Thus, farmers
will be forced to buy new seeds every year. This will raise their production costs
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considerably. Moreover, in order to insure that no seeds are saved GM companies came
up with the Genetic Use Restriction Technologies (GURTs). Seeds obtained through this
technology produce sterile generation. That is why it is mostly known by the name
“terminator technology.” In some case a certain chemical can activate sterile offspring.
This further suggests that the company-innovator decreases its cost (no need for a seed
turnover) and increases the costs for the farmers (price o f the initial seed plus the price
for the activating chemical). However, “terminator technology” is still an object of wide
discussion.

Due to the fact that the regulations for the IPRs differ from country to country, the
amount of use of the GM seeds varies also. For instance, in some countries, farmers were
sued for patent violation. Most developing countries do not have patent regulations for
GM products; thus, GE-giants do not trade with those countries or charge royalties in
another manner. One of such ways is to impose a shipment fee on GM products from the
country-producer without patent protection to a country that has it (e.g. Argentina and the
US). Strict IPRs may also decrease the level of independent research due to the fact that
scientists would have to collaborate with owners o f the technology for the “use” of their
product. The absence o f the patent regulation may also cause some scientists to decline
from the research in such countries (applicable to the most developing countries). Thus,
the needs o f these countries in the field of biotechnology will not be addressed.
Governments o f the individual countries have to consider what are the long-term effects
of the patent law implementation.
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6. H Public Opinion

Another social factor that plays an important role in understanding significance of
GM technology is public opinion. As previously stated, a strong argument for the GM
technology is its claimed ability to “feed the world” and alleviate poverty. However, as it
was also noticed earlier the entire world population can be fed with a balanced diet as of
today and for the next thirty years without interference o f the GM technology (Pew
Initiative, 2001). The real causes o f hunger are inequality of income distribution, poor
governance, poverty, and accessibility. In addition, the public perception o f the GMOs
can be biased due to the distrust of its own government and its ability to protect health of
its citizens (example o f EU).

6 . 1. Culture, Religion, and Ethics

Some of the least discussed but nonetheless extremely important socio-economic
factors are the cultural, religious, and ethical implications regarding GM technology.
Integrity or autonomy is one of the ethical considerations. It stresses the right and the
ability of an individual to be informed and make choices based on that information. In the
USA and most countries in the world, such a choice was not given to the consumers. As
of today, there is still now adequate segregation and labeling o f the GM products. Also,
farmers who do not want to apply biotechnology to their production process should be
ensured that they will be able to do so (e.g. problems o f contamination and pests
resistance). The farmers who want to embrace GM technology should be given a right to
do so; however, the public should be assured that their GM products are safe for the
environment and human health.
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Another ethical principle to consider with respect to GMOs is the utilitarian
approach. It uses the cost and benefit calculations in order to determine the direction of
actions that would bring the most good to the most number o f people (Purchase, 2002).
On this basis supporters of the GM technology cite the fact that the benefits of “feeding
the hungry” outweighs all the risks associated with it. On the other hand, opponents of
the biotechnology argue that “playing with nature” at the gene level is unacceptable
regardless of the possible benefits. Moreover, they argue that ecosystems and species
have intrinsic value and should be protected at their initial state (Myhr, 2000). Many
would argue that humans have been changing nature throughout history and thus there is
no need to impose restrictions on GM technology at this time. However, the change that
is about to happen due to the GM technology is very radical; in a sense, not only the
world will never be the same, it might become a place that is foreign to humanity itself.

The cultural implications o f genetic engineering, or a specific GMO, became an
ongoing issue in the recent years. It should be recognized that for some cultures the
adoption o f GE might be unacceptable or only partially acceptable. For instance, in some
communities, a certain level o f biological diversity that is important to their culture can
be ruined due to the introduction of the GE technology (e.g. GM maize in Mexico). These
effects have to be counted when evaluating costs and benefits o f the GE.

The religious concern is another issue rising from the development o f the genetic
engineering. Some argue that the alteration of the life form on such a level and then
patenting it (claiming the life-ownership) is blasphemy (Warner, 2001). Moreover, many
religions in the world (Christianity, Hinduism, Islam, Judaism) practice certain dietary
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restrictions. Appearance of the GM products in the food chain (especially without
segregation and labeling) can make these practices impossible and thus, will undermine
religious believes of millions of people.

The enormous variety of ethical issues, cultural believes, and religions does not
allow for the development o f unified approach o f accessing benefits and costs of the
genetic engineering. Different countries and different cases will take diverse directions in
evaluating genetic engineering. However, an independent recommendation for specific
government is not to discount ethical, cultural, and religious factors when considering the
adoption of the GE technology. Recommendations can be also made to the public: social
dialog, extensive discussions with various groups present, and constant exchange of
information should take place. On the basis of the discussion above and independent
discoveries of the author, assessment o f the methodological approach for evaluating
impacts of the genetic engineering will be introduced in the next section.
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7. Types and Approaches to Research Methodology. Assessment o f the Cost
Benefit Analysis for the GM Products

The integration of socio-economic factors into bio-safety decisions is by no
means an easy task. At the present stage, two steps are necessary: first, research in the
social science field is vital in order to identify and clarify socio-economic issues relevant
to biotechnology in different national contexts and recognizing actual effects o f the
GMOs implementation on this particular environments; second, regulatory processes
have to be applied in order to address those socio-economic issues. Today, the decision o f
introduction and adoption of a certain GM crop lies in the hands of the producers and the
policy-makers. The voices o f farmers, consumers, and public in general are silenced. That
is why the emergence o f a holistic methodological approach o f assessing effects of the
GM products is so important. It has to be noted that any methodology has its limitations.
That is why the choice of the methodology should be done on a country-by-country or
even a case-by-case basis. We will list few available methodologies and then develop one
of them.

Economic Modeling

Economic modeling is one of the approaches that can be taken. The main goal o f
it is to predict the economic effects of a certain policy. However, more targeted questions
can be answered such as which country will lose or benefit economically from the
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adoption of GE products. Another useful tool can be a social impact assessment. This
methodology is one to use when environmental concerns o f adopting the GE technology
is high. Thus, social impact assessment includes the environmental factors into its
analysis. SIA can estimate the likelihood and the intensity of the potential impact of
biotechnology, specifically, its effects on certain social groups. Both the advantage and
disadvantage of this method is use of the quantitative and qualitative data. The latter is
argued to have some subjectivity. However, it is still a very useful tool, especially in the
cases where environmental impact evaluation is needed. For instance, it can answer the
question on equity and thus provide a useful basis for the decision-making process.

Sustainable Livelihood Framework

Yet another method o f socio-economic analysis is Sustainable Livelihood
Framework developed by the U K ’s department for International Development. The main
tools of this method are: surveys, focus groups, interviews, household case studies, and
secondary data. It uses all the data collected to track the connections between the
household, community, and regional levels for better understanding o f the true
underlying problems. This type of research can successfully address some of the socio
economic factors that were discussed in the previous section (e.g. distribution o f wealth
and benefits) in relation to the technology of genetic modification.

Systemic Relevance Assessment

One of the other comparatively new methods of socio-economic analysis is the
“Systemic relevance assessment.” It is said to be useful in identifying the relevance o f a
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certain GM crop. The evaluation is conducted on two levels: first, measuring the ability
of the GM crop to address specific agricultural problems; second, measuring the ability of
the crop to address needs of the farmers and fit within the general public’s goals. This
method also has advantage o f cross-dependency analysis (ex, between farmers and
producers). Thus, this method shifts focus from the innovation itself to a specific problem
that this GM crop can address or solve in the context o f a specific community.

Priority Setting through Participatory Research

Yet another methodological approach is Priority-Setting through participatory
research. This method in a sense is very unique. It concentrates on targeting and
developing new GM products for alleviation of poverty. Apart form the method before,
farmers are given the privilege to choose and select specific seeds (thus preserving a
century-long tradition o f seed-selection by farmers). Participatory research stresses the
importance of including all of those that are affected by the new technology (mostly
consumers and farmers).

Cost Benefit Analysis

The last methodological approach that is going to be presented is a Cost Benefit
Analysis. It is very useful quantitative tool in measuring different opportunity costs and
trade-offs of various approaches to genetic engineering. In 2003, Hall and Morgan
assessed A Partial Cost Benefit Analysis o f the Introduction o f the Genetically Modified
Oilseed Rape Crops and Food to Scotland. It can be discovered very easily that a direct
valuation method (ascribing monetary value for different social, health, and
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environmental risks) will be highly complicated. Authors o f the study mentioned above
offered an indirect valuation that “clarifies the opportunity cost o f not advancing the
technological development and then asks whether society values the avoidance o f
potential costs by this much” (Hall et ah, 2003). When the costs and benefits are
evaluated the best scenario program is chosen (the one with highest net present value). In
their study, Hall and Morgan assessed benefits and costs for three separate categories:
economic, environmental, and social. The main categories (groups that are affected by
the implementation of a certain policy) that were identified for this particular study were
GM farmers, non-GM farmers, local communities, GM companies, research institutions,
secondary markets, consumers, and the government. The advantage o f this methodology
is that it can assess the same issue from different standpoints. For instance, the costs and
benefits can be evaluated from the point of view o f the consumers only. Another
scenario: evaluation from the point of view of the biotechnology companies. It can be
also evaluated from the point o f view of society as a whole. This became to be known as
“standing.” Thus, results o f the cost and benefits analysis of a specific GM crop might
change depending on who has the standing. CBA relies on the socio-economic research
and the public involvement to gather needed information about value o f the technology’s
benefits and the value o f avoiding its potential costs. Costs and benefits can be
considered based on the factors discussed in the section 6. A o f the present paper (such as
markets, competition, trade, etc.). However, the disadvantage o f this method is it lacks
the qualitative analysis. Thus, answering such question as what are the costs and benefits
with respect to religion, culture, and ethics becomes nearly impossible. Thus, for
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effective decision-making purposes, results of the CBA analysis should be combined
with, for instance, results of the sustainable livelihoods framework.

Based on discussion of socio-economic factors o f GM crops presented in the
previous section, I will assess a CBA analysis framework specifically with regard of
those factors. One of the first socio-economic factors that have been discussed is
distribution of benefits. CBA has to thoroughly approach this implication of GMOs by
asking a question o f how are the benefits and costs of the introduction of a certain GM
product distributed amongst different societal groups. The second factor was public
sector research and development. With regard to this factor, CBA has to evaluate how
different R&D approaches affect various institutions. For instance, how will the results of
CBA differ if they done by a public versus private agency and how these results are going
to affect other institutions (e.g. FDA, EC, etc.)? In regards to the labor as a socio
economic implication of the GMOs, CBA has to be concerned with the question how will
laborers and employees profit or lose with the introduction o f various GM products.
“Markets” is another socio-economic factor that was discussed previously. In assessing
CBA one has be concerned with which types o f markets will benefit or lose (e.g. GM
markets verses conventional or organic markets), what will be the effects on competition,
what will be the consequences for the dependants of these markets? In the legal sphere,
CBA has been concerned with intellectual property rights. The questions that have to be
answered are what are the costs and benefits related to IPRs, how they affect producers,
consumers, and research companies? As it was noted before, qualitative estimations are
not the strongest part o f CBA, however, some questions on ethic, culture, and religion
can be assessed. That is, is there a monetary loss and control loss for some consumer and
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farmers over their production and consumption choices with respect to the new GM
product implementation? When assessing CBA, analysis standing plays crucial role. The
final results of the CBA or the net present value estimation depend directly on the choice
of standing. The author o f the present paper believes that considerations and the
assessment of the CBA has to be done from the societal perspective first and if the
resources enable the researcher to conduct further analysis only then separate societal
sectors have to be considered. Following steps o f the CBA would include identifying
benefits and costs for each o f the socio-economic factors discussed above, estimating
them in present value terms to assess long-term changes (note, choice of the discount rate
will affect these estimation), and calculating net present value o f the project. Based on the
results recommendations can be made o f how beneficial to the society the
implementation and adoption of a particular GM crop could be. However, attaining the
results is not an end in itself; they have to be incorporated into the decision-making
process. There are four stages to bio-safety decision-making: the development o f a
domestic bio-safety “regulatory regime,” risk assessment for a certain GMO, short period
after risk assessment, and grant or extension of the permit for import or adoption o f a
certain GM product. In this light, CBA has an advantage before other methodologies; it
can be carried out on the very early stages of the decision-making process.

The list o f the methodological approaches above is not final and each o f the
approaches has limitations. However, these methodologies can offer comprehensive
analyses of the real impacts of the GMOs, conclusions o f which can be successfully
incorporated into the decision-making process on the bio-safety issues.
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8. Conclusions and Recommendations

At last, we are able to answer questions that were raised at the beginning o f this
paper. In general, the development and diffusion o f GM technology is well-described by
Shumpeter’s “process o f creative destruction.” Although, there is a lot o f uncertainty and
disagreement around genetic engineering today, the technology and its products steadily
make their way onto the market. We can affirmatively say that if no extensive (and
widely accepted) evidence of the harmful effects o f GM technology on human health and
environment can be presented in the future, it will become the leading technology in
agriculture. The premises to this already exist: the wide support o f GM by the
government, industry producers, and the amount o f research and development being put
into the technology.

The main trends of the industry are: heavy investment in the research and
development, vertical integration, world expansion, and high tendency o f the firms to
consolidation through formal and informal agreements. The analysis presented in this
paper confirms that GE companies and the market in general have absolute and
comparative advantage before the conventional industry through the ability to decrease
the production costs almost in half with GM technology. Having this advantage, leading
industry players, moved by the high profits, will eventually exploit gained market power.
Already, this tendency can be noted.
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Based on our analysis, the GM products being introduced into the market are not
benefiting consumers or farmers. For example, farmers must pay for the seeds and for the
chemicals annually, since in most cases they cannot reproduce the seeds for the second
year. Also, as a result of more concentration in the agricultural industry, farmers will
produce fewer wholesome produce and the market in general will be split between a few
large corporations. Consumers, on the other hand, because they are not properly informed
about the new technology, are not given a fair choice o f accepting or rejecting it.
Organics are used as a higher-priced reference, so there is always “a cheaper” version of
the same product offered. GE companies claim that they are working for the good of the
consumers, farmers, and those in need (e.g. poor African people). However, the products
that have been introduced on the market so far by large benefit corporations (African
Center for Biosafety, 2006). Moreover, the more market power biotechnology companies
gain the more incentive they will have to engage in price gouging. This will lead to lower
consumer surplus and fewer consumer choices. Moreover, as discussed in this paper, the
effects of the GE products on the human and animal health and the ecosystem are still not
clear.

GE technology has also stimulated sales for pharmaceutical and chemical
industries. The latter has benefited from the chemical resistant technology. What is more
peculiar is that GE companies do not come up with crops that do not require
complementary products or crops that proliferate for more than a year. This very fact
exposes the true intensions that GE companies are after: market power and high profits.
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The debate around Genetic Modification suggests that biotechnology is still risky
business. For example, USDA officially recalled 500,000 bushels of soybeans because
they were contaminated by the GM maize destined to produce vaccine for pigs. Most
definitely, this kind o f “product uncertainty” will raise any company’s costs. Thus, gene
flow remains a problem and a barrier for the industry growth and development. Most GE
companies are hoping for the development of a third generation o f the biotech crops that
can avoid this problem. It is also possible that the industry will be able to solve the
discussed social issues and bring cost-efficiency to the agricultural, pharmaceutical, and
food markets, thus, building strong advantage relative to the conventional agricultural
industry.

In a sense, the change from conventional forms o f farming to GE farming is a
radical innovation related to the power o f gene manipulation. Perfect fruit and vegetables
grown every time, grains that are not affected by weeds and insects, crops that can
withstand even the most harsh conditions on Earth - these are the great promises o f GM
technology.

This paper posed the question: “Can Genetic Modification really benefit humans
and nature without bringing harm?” Unfortunately, today there is no definite answer to
this question. GE technology has great potentials; however, great caution should be
exercised by the interested parties (especially consumers and the scientific society) in
approaching the issue o f genetic modification. More sophisticated and extensive research
should be done in this field. GE opponents would argue that GM technology only
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benefits industry producers of GM products and the governments, but at the same time it
imposes health and social threats to society.

At the present, it is difficult to side exclusively with either argument. They both
have strengths and weaknesses. For instance, groups that are against GE do not have
“agreed upon” criteria that are accepted by the scientific society facts o f the negative
effects of the GM products on human health and the environment (only individual
scientific research is available). On the other hand, GE proponents compare positive
effects o f genetic modification only with chemical-based farming and do not consider
organic farming and dismiss the health concerns all together. Moreover, their best
argument for genetic engineering is its ability to deal with world’s hunger. However, it is
obvious that the problems of poverty and starvation do not lie in the agricultural sphere
(Food and Agriculture Organization o f the United Nations, 2000). According to the
analysis presented in this paper, there is not much evidence o f societal benefits from GM
technology. Even the positive effects of it can become negative in a long-term situation.
Long-term costs, benefits, and risks o f Genetic Modification remain largely unknown. In
the opinion o f the author, a holistic approach is needed. The social, economic, and
political effects need more study to help address environmental and health concerns. The
following recommendations can be made:

•

To incorporate public sector research and development into overall development
process of the new GE crops.

•

To conduct studies targeted on the issues related to the labor markets to assess
specific effects of the introduction o f the GM products on this market
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•

To obtain (for the government) relevant information on crops produced domestically,
to collect information on their GM match produced abroad, to define the direction of
exports of such crops and the consumer attitudes toward GM products on these
markets.

•

To clarify (for the government) trade policies on GM products and, since a favorable
degree o f certainty is still not achieved, to press global communities for a distinct
segregation and labeling of such products.

•

To consider the costs and benefits with respect to changes in competition. Moreover,
the importance of public research and development can be called in help.

•

To consider what are the long-term effects of the patent law implementation
regarding GM products

•

Not to discount ethical, cultural, and religious factors when considering the adoption
of the GE technology. Recommendations can be also made to the public: social
dialog, extensive discussions with various groups present and constant exchange of
information should take place.

Moreover, in the light o f two strong tendencies - fast concentration o f GM markets
and rapid development of the GE technology - emergence o f a new and comprehensive
methodological approach is needed in order to address socio-economic implications of
the genetic engineering and effectively incorporate them into the bio-safety decision
making process. Ultimately, the question about safety o f GM foods is a question about
the well being o f people and nature.
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Appendices
Appendix 1.

Table 1. Total Acres of GM Crops Planted and Percentage of all Crops
that were GM in June 2003
Top GM soybean producing states

Top GM com producing states

North Dakota: 2,294 74%

South Dakota: 3,375 75%

South Dakota: 3,731 91%

Nebraska: 4,160 52%

Nebraska: 4,042 86%

Kansas: 1,363 47%

Kansas: 2,349 87%

Minnesota: 3,763 53%

Minnesota: 6,004 79%

Iowa: 5,580 45%

Iowa: 8,736 84%

Missouri: 1,239 42%

Missouri: 4,109 83%

Wisconsin: 1,184 32%

Arkansas: 2,436 84%

Illinois: 3,108 28%

Wisconsin: 1,344 84%

Michigan: 805 35%

Illinois: 8,162 77%

Indiana: 912 16%

Mississippi: 1,210 89%

Ohio: 311 9%

Michigan: 1,533 73%
Indiana: 4,752 88%
Ohio: 3,256 74%
Source: World Trade Organization; U.S. Dept, o f Agriculture; N.A.S.S.
Acreage Reports, 2003
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Appendix 2, Table 7 and 8.

Table 7. * Number Rat Pups Died from the Litter of Individual Mothers
on the GM-soy Flour Supplemented Diet____________ ________________
Number of newborn

Number o f cpups

Number o f dead

rats

died

pups/bom (%)

Female No. 1

11

7

64%

Female No. 2

8

4

50%

Female No. 3

13

6

46%

Female No. 4

13

8

62%

Females

Table 8. * Examples of Absolute Values of Organ Mass in Pups in Three
NN
N26

Body
69

Fiver
3.80

Lungs
1.20

Heart
0.37

Kidneys
0.44/0.44

Spleen
0.52

Testes
0.34/0.34

Brain
1.67

Normal
N27

72

4.63

1.55

0.38

0.52/0.42

0.81

0.3/0.3

1.6

Normal
N28

35

1.83

0.6

0.19

0.28/0.28

0.21

0.13/0.14

1.60

GM-soy
N29

30

1.68

0.5

0.20

0.19/0.20

0.19

0.14/0.18

1.54

GM-soy
N30

62

4.28

0.95

0.36

0.38/0.38

0.24

0.22/0.26

1.76

T ra d soy
N31

63

4.35

0.94

0.39

0.42/0.42

0.32

0.22/0.23

1.66

Trad-soy
Source**: Ermakova, I. V. (2005). Influence o f Genetically Modified-SOYA on the BirthWeight and Survival o f Rat Pups: Preliminary Study. Institute o f Higher Nervous
Activity and Neurophysiology, Russian Academy of Science (RAS). Retrieved from
www.mindfully.org
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